Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Migraine

Free Subscription Articles published in Neurology Retrieve available abstracts of 88 articles: HTML format

Single Articles

September 2024
1. KUMAR A, Joshi D, Singh VK
   Harlequin Syndrome: A Rare Association With Migraine.
   Neurology. 2024;103:e209792.
   PubMed    
   
   
   
2. SCHULZ RS, Glatz T, Buring JE, Rist PM, et al
   Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
   Neurology. 2024;103:e209747.
   PubMed     Abstract available
   
   
   
3. LIPTON RB, Harriott AM, Ma JY, Smith JH, et al
   Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial.
   Neurology. 2024;103:e209745.
   PubMed     Abstract available
   
   
   August 2024
4. AL-HASSANY L, Acarsoy C, Ikram MK, Bos D, et al
   Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The Population-Based Rotterdam Study.
   Neurology. 2024;103:e209700.
   PubMed     Abstract available
   
   
   July 2024
5. GOADSBY PJ, Friedman DI, Holle-Lee D, Demarquay G, et al
   Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
   Neurology. 2024;103:e209584.
   PubMed     Abstract available
   
   
   May 2024
6. CHRISTENSEN RH, Ashina H, Al-Khazali HM, Zhang Y, et al
   Differences in Cortical Morphology in People With and Without Migraine: A Registry for Migraine (REFORM) MRI Study.
   Neurology. 2024;102:e209305.
   PubMed     Abstract available
   
   
   
7. REUTER U, Goadsby PJ, Ferrari MD, Da Silva Lima GP, et al
   Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed: LIBERTY 3-Year Study.
   Neurology. 2024;102:e209349.
   PubMed     Abstract available
   
   
   April 2024
8. DE HAVENON A, Callaghan BC, Xu Y, Connor M, et al
   Burden of Neurologic Health Care and Incident Neurologic Diagnoses in the Year After COVID-19 or Influenza Hospitalization.
   Neurology. 2024;102:e209248.
   PubMed     Abstract available
   
   
   
9. VAN OOSTERHOUT WPJ, Perenboom MJL, Terwindt GM, Ferrari MD, et al
   Frequency and Clinical Features of Space Headache Experienced by Astronauts During Long-Haul Space Flights.
   Neurology. 2024;102:e209224.
   PubMed     Abstract available
   
   
   February 2024
10. LATEEF TM, Dey D, Leroux A, Cui L, et al
    Association Between Electronic Diary-Rated Sleep, Mood, Energy, and Stress With Incident Headache in a Community-Based Sample.
    Neurology. 2024;102:e208102.
    PubMed     Abstract available
    
    
    
11. PIZER JH, Aita SL, Myers MA, Hawley NA, et al
    Neuropsychological Function in Migraine Headaches: An Expanded Comprehensive Multidomain Meta-Analysis.
    Neurology. 2024;102:e208109.
    PubMed     Abstract available
    
    
    
12. SHAPIRO RE, Nicholson RA, Seng EK, Buse DC, et al
    Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life.
    Neurology. 2024;102:e208074.
    PubMed     Abstract available
    
    
    
13. KEMPNER J
    Brains Under Siege: Assessing the Harmful Effects of Migraine-Related Stigma.
    Neurology. 2024;102:e209192.
    PubMed    
    
    
    January 2024
14. HVITFELDT FUGLSANG C, Pedersen L, Schmidt M, Vandenbroucke JP, et al
    Combined Impact of Migraine and Pregnancy-Induced Hypertension on Long-term Risk of Premature Myocardial Infarction and Stroke.
    Neurology. 2024;102:e207813.
    PubMed     Abstract available
    
    
    November 2023
15. CHIANG CC, Fang X, Horvath Z, Cadiou F, et al
    Simultaneous Comparisons of 25 Acute Migraine Medications Based on 10 Million Users' Self-Reported Records From a Smartphone Application.
    Neurology. 2023 Nov 29:10.1212/WNL.0000000000207964.
    PubMed     Abstract available
    
    
    
16. FRIEDMAN SA, Robbins MS
    Millions of Migraine Attacks, Many Answers, More Questions.
    Neurology. 2023 Nov 29:10.1212/WNL.0000000000208084.
    PubMed    
    
    
    August 2023
17. FRIEDMAN BW, Solorzano C, Kessler BD, Martorello K, et al
    Randomized Trial Comparing Low- vs High-Dose IV Dexamethasone for Patients With Moderate to Severe Migraine.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207648.
    PubMed     Abstract available
    
    
    
18. VANDERPLUYM JH, Victorio MCC, Oakley CB, Rastogi RG, et al
    Beyond the Guidelines: A Narrative Review of Treatments on the Horizon for Migraine in Children and Adolescents.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207677.
    PubMed     Abstract available
    
    
    July 2023
19. VANDERPLUYM JH
    Variation in Endpoints in FDA Approvals for Acute and Preventive Migraine Medications: Striving to Compare Apples to Apples.
    Neurology. 2023 Jul 12:10.1212/WNL.0000000000207672.
    PubMed    
    
    
    
20. SHARPLESS LK, Kesselheim A, Orr SL, Darrow J, et al
    Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications.
    Neurology. 2023 Jul 12:10.1212/WNL.0000000000207544.
    PubMed     Abstract available
    
    
    
21. PONDER M, Wood ME
    Periconceptional Use of OnabotulinumtoxinA: Need for Comparative Safety Studies.
    Neurology. 2023;101:53-54.
    PubMed    
    
    
    June 2023
22. LIU J, Quan S, Zhao L, Yuan K, et al
    Evaluation of a Clustering Approach to Define Distinct Subgroups of Patients With Migraine to Select Electroacupuncture Treatments.
    Neurology. 2023 Jun 22:10.1212/WNL.0000000000207484.
    PubMed     Abstract available
    
    
    May 2023
23. ORNELLO R, Sposato LA, Sacco S
    Author Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1033.
    PubMed    
    
    
    
24. LEWIS A, Galetta S
    Editors' Note: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1032.
    PubMed    
    
    
    
25. SCUTELNIC A, Jung S, Schankin CJ
    Reader Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1032-1033.
    PubMed    
    
    
    April 2023
26. KARCESKI S
    Migraine and Hormones: A Complex Interaction.
    Neurology. 2023;100:e1849-e1851.
    PubMed    
    
    
    
27. BARBANTI P, Aurilia C, Egeo G, Torelli P, et al
    Late Response to Anti-CGRP Monoclonal Antibodies in Migraine: A Multicenter, Prospective, Observational Study.
    Neurology. 2023 Apr 18:10.1212/WNL.0000000000207292.
    PubMed     Abstract available
    
    
    
28. 
    Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2.
    Neurology. 2023 Apr 4:10.1212/WNL.0000000000207168.
    PubMed    
    
    
    March 2023
29. BENKLI B, Kim SY, Koike N, Han C, et al
    Circadian Features of Cluster Headache and Migraine: A Systematic Review, Meta-analysis, and Genetic Analysis.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207240.
    PubMed     Abstract available
    
    
    
30. SUTHERLAND H, Griffiths L
    It's All About the Timing: Circadian Factors in Cluster Headache and Migraine.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207329.
    PubMed    
    
    
    February 2023
31. RAFFAELLI B, Storch E, Overeem LH, Terhart M, et al
    Sex Hormones and Calcitonin Gene-Related Peptide in Women With Migraine: A Cross-sectional, Matched Cohort Study.
    Neurology. 2023 Feb 22:10.1212/WNL.0000000000207114.
    PubMed     Abstract available
    
    
    January 2023
32. VANDERPLUYM JH
    Adverse Pregnancy Outcomes and Migraine: What We Know and What We Can Do.
    Neurology. 2023 Jan 25:10.1212/WNL.0000000000207089.
    PubMed    
    
    
    
33. PURDUE-SMITHE AC, Stuart JJ, Farland LV, Kang JH, et al
    Prepregnancy Migraine, Migraine Phenotype, and Risk of Adverse Pregnancy Outcomes.
    Neurology. 2023 Jan 19:10.1212/WNL.0000000000206831.
    PubMed     Abstract available
    
    
    
34. LAX DN, Kabbouche M, Kacperski J, Hershey AD, et al
    Clinical Reasoning: A Teenager With Right-Sided Headache and Periorbital Changes.
    Neurology. 2023;100:144-150.
    PubMed     Abstract available
    
    
    
35. HORTON MK, Robinson SC, Shao X, Quach H, et al
    A Cross-Trait, Mendelian Randomization Study to Investigate Whether Migraine Is a Risk Factor for Multiple Sclerosis.
    Neurology. 2023 Jan 11:10.1212/WNL.0000000000206791.
    PubMed     Abstract available
    
    
    December 2022
36. UNDERWOOD M, Achana F, Carnes D, Eldridge S, et al
    A Supportive Self-Management Program for People With Chronic Headaches and Migraine: A Randomized Controlled Trial and Economic Evaluation.
    Neurology. 2022 Dec 16:10.1212/WNL.0000000000201518.
    PubMed     Abstract available
    
    
    
37. SACCO S, Harriott AM, Ayata C, Ornello R, et al
    Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2022 Dec 15:10.1212/WNL.0000000000201699.
    PubMed     Abstract available
    
    
    November 2022
38. LIPTON RB, Pozo-Rosich P, Blumenfeld A, Li Y, et al
    Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial.
    Neurology. 2022 Nov 17. pii: WNL.0000000000201568.
    PubMed     Abstract available
    
    
    
39. KOPEL D, Gottschalk CH
    Migraine--Not Just a Numbers Game: Aim to Improve Quality of Life.
    Neurology. 2022 Nov 17. pii: WNL.0000000000201566.
    PubMed    
    
    
    October 2022
40. DE VRIES LENTSCH S, Heleen van der Arend BW, Maassen van den Brink A, Terwindt GM, et al
    Blood Pressure in Migraine Patients Treated With Monoclonal Anti-CGRP (receptor) Antibodies: A Prospective Follow-up Study.
    Neurology. 2022 Oct 4. pii: WNL.0000000000201008.
    PubMed     Abstract available
    
    
    September 2022
41. ORR SL
    Status Migrainosus: One of the Most Poorly Understood but Important Complications of Migraine.
    Neurology. 2022 Sep 29. pii: WNL.0000000000201477.
    PubMed    
    
    
    
42. VANDERPLUYM JH, Mangipudi K, Mbonde AA, Gritsch D, et al
    Incidence of Status Migrainosus in Olmsted County, Minnesota, United States: Characterization and Predictors of Recurrence.
    Neurology. 2022 Sep 29. pii: WNL.0000000000201382.
    PubMed     Abstract available
    
    
    
43. AILANI J, Kaiser EA, Mathew PG, McAllister P, et al
    Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine-Clinical Considerations: A Narrative Review.
    Neurology. 2022 Sep 20. pii: WNL.0000000000201332.
    PubMed     Abstract available
    
    
    
44. SENG EK, Fenton BT, Wang K, Lipton RB, et al
    Frequency, Demographics, Comorbidities, and Health Care Utilization by Veterans With Migraine: A VA Nationwide Cohort Study.
    Neurology. 2022 Sep 13. pii: WNL.0000000000200888.
    PubMed     Abstract available
    
    
    August 2022
45. IGHODARO E, Ghislain B, Scharf E, Robertson CE, et al
    Pearls & Oysters: Post Pipeline Headache Phenomenon: Nummular Headache Presenting After Intracranial Aneurysm Stenting.
    Neurology. 2022 Aug 26. pii: WNL.0000000000201157.
    PubMed     Abstract available
    
    
    
46. IBRAHIMI K, Rist PM, Carpenet C, Lee Rohmann J, et al
    Vascular Risk Score and Associations With Past, Current, or Future Migraine in Women: Cohort Study.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201009.
    PubMed     Abstract available
    
    
    
47. SACCO S, Sposato LA
    The Challenging Puzzle of Migraine, Age, and Vascular Health.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201071.
    PubMed    
    
    
    
48. ADDERLEY NJ, Subramanian A, Perrins M, Nirantharakumar K, et al
    Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201064.
    PubMed     Abstract available
    
    
    
49. LIPTON RB, Dodick D, Goadsby PJ, Burstein R, et al
    Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain Versus Moderate or Severe Pain.
    Neurology. 2022 Aug 17. pii: WNL.0000000000201031.
    PubMed     Abstract available
    
    
    
50. GALLARDO VJ, Alpuente A, Pozo-Rosich P
    Association of a Cyclical Migraine Phenotype With Disease Progression: A One-Year Time Series Analysis.
    Neurology. 2022 Aug 11. pii: WNL.0000000000200887.
    PubMed     Abstract available
    
    
    July 2022
51. COFFMAN C, Reyes D, Hess MC, Giakas AM, et al
    Relationship Between Headache Characteristics and a Remote History of TBI in Veterans: A 10-Year Retrospective Chart Review.
    Neurology. 2022;99:e187-e198.
    PubMed     Abstract available
    
    
    
52. ROSENDALE N, Guterman EL, Obedin-Maliver J, Flentje A, et al
    Migraine, Migraine Disability, Trauma, and Discrimination in Sexual and Gender Minority Individuals.
    Neurology. 2022 Jul 11. pii: WNL.0000000000200941.
    PubMed     Abstract available
    
    
    April 2022
53. MORRIS C, Ross A, Greene K, Irwin S, et al
    Outcomes That Matter to Adolescents With Continuous Headache Due to Chronic Migraine and Their Parents: A Pilot Survey Study.
    Neurology. 2022 Apr 13. pii: WNL.0000000000200292.
    PubMed     Abstract available
    
    
    March 2022
54. DOHRN MF, Rebelo AP, Srivastava S, Cappuccio G, et al
    De Novo ATP1A1 Variants in an Early-Onset Complex Neurodevelopmental Syndrome.
    Neurology. 2022;98:440-445.
    PubMed     Abstract available
    
    
    February 2022
55. SCHER AI, Bendtsen L
    Patient-Centered Treatment of Chronic Migraine With Medication Overuse: More Is Not Always Better.
    Neurology. 2022 Feb 15. pii: WNL.0000000000200252.
    PubMed    
    
    
    
56. MCELWEE DECKER B, Thibault D, Davis KA, Willis AW, et al
    Population-Based Study of Nonelective Postpartum Readmissions in Women With Stroke, Migraine, Multiple Sclerosis, and Myasthenia Gravis.
    Neurology. 2022 Feb 15. pii: WNL.0000000000200007.
    PubMed     Abstract available
    
    
    
57. SCHWEDT T, Hentz J, Sahai-Srivastava S, Murinova N, et al
    Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial.
    Neurology. 2022 Feb 15. pii: WNL.0000000000200117.
    PubMed     Abstract available
    
    
    January 2022
58. DUMKRIEGER G, Chong CD, Ross K, Berisha V, et al
    Differentiating Between Migraine and Post-traumatic Headache Using a Machine Learning Classifier.
    Neurology. 2022;98.
    PubMed     Abstract available
    
    
    
59. ISHII R, Dodick DW, Trivedi M, Dumkrieger G, et al
    A History of Mild Traumatic Brain Injury Is Associated With a a More Severe Long-term Migraine Phenotype.
    Neurology. 2022;98.
    PubMed     Abstract available
    
    
    October 2021
60. MACGREGOR EA
    Differences Between Perimenstrual Migraine Attacks and Migraine Attacks at Other Times of the Cycle.
    Neurology. 2021;97:e1753-e1756.
    PubMed    
    
    
    
61. RIANT F, Roos C, Roubertie A, Barbance C, et al
    Hemiplegic Migraine Associated With PRRT2 Mutations: A Clinical and Genetic Study.
    Neurology. 2021 Oct 14. pii: WNL.0000000000012947.
    PubMed     Abstract available
    
    
    
62. GUO Y, Daghlas I, Gormley P, Giulianini F, et al
    Phenotypic and Genotypic Associations Between Migraine and Lipoprotein Subtractions.
    Neurology. 2021 Oct 11. pii: WNL.0000000000012919.
    PubMed     Abstract available
    
    
    September 2021
63. STANYER EC, Creeney H, Nesbitt AD, Robert Holland PR, et al
    Subjective Sleep Quality and Sleep Architecture in Patients With Migraine: A Meta-analysis.
    Neurology. 2021 Sep 22. pii: WNL.0000000000012701.
    PubMed     Abstract available
    
    
    
64. KAISER EA, McAdams H, Igdalova A, Haggerty EB, et al
    Reflexive Eye Closure in Response to Cone and Melanopsin Stimulation: A Study of Implicit Measures of Light Sensitivity in Migraine.
    Neurology. 2021 Sep 7. pii: WNL.0000000000012734.
    PubMed     Abstract available
    
    
    
65. VAN CASTEREN DS, Verhagen IE, van der Arend BWH, van Zwet EW, et al
    Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary.
    Neurology. 2021 Sep 7. pii: WNL.0000000000012723.
    PubMed     Abstract available
    
    
    August 2021
66. SCHANKIN CJ, Denier N, El-Koussy M, Wiest R, et al
    Author Response: The Index Vein Pointing to the Origin of the Migraine Aura Symptom: A Case Series.
    Neurology. 2021;97:402.
    PubMed    
    
    
    
67. BUGNICOURT JM, Godefroy O
    Reader Response: The Index Vein Pointing to the Origin of the Migraine Aura Symptom: A Case Series.
    Neurology. 2021;97:401-402.
    PubMed    
    
    
    July 2021
68. CARVALHO G, Mehnert J, Basedau H, Luedtke K, et al
    Brain Processing of a Visual Self-Motion Study in Patients With Migraine: An fMRI Study.
    Neurology. 2021 Jul 21. pii: WNL.0000000000012443.
    PubMed     Abstract available
    
    
    April 2021
69. MACDONALD CJ, El Fatouhi D, Madika AL, Fagherazzi G, et al
    Association of Migraine With Incident Hypertension After Menopause: A Longitudinal Cohort Study.
    Neurology. 2021 Apr 21. pii: WNL.0000000000011986.
    PubMed     Abstract available
    
    
    
70. GHANIZADA H, Al-Mahdi Al-Karagholi M, Arngrim N, Morch-Rasmussen M, et al
    Effect of Adrenomedullin on Migraine-like Attacks in Patients With Migraine: A Randomized Crossover Study.
    Neurology. 2021 Apr 7. pii: WNL.0000000000011930.
    PubMed     Abstract available
    
    
    
71. LIPTON RB, Buse DC, Friedman BW
    Author Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:686.
    PubMed    
    
    
    
72. MINEN MT
    Reader Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:685.
    PubMed    
    
    
    
73. LIPTON RB, Buse DC, Friedman BW
    Author Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:684-685.
    PubMed    
    
    
    
74. BLUMENFELD A
    Reader Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:684.
    PubMed    
    
    
    
75. LIPTON RB, Buse DC, Friedman BW
    Author Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:683-684.
    PubMed    
    
    
    
76. GUPTA VK
    Reader Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:683.
    PubMed    
    
    
    
77. GANESH A, Galetta S
    Editors' Note: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:682.
    PubMed    
    
    
    
78. GUO Y, Rist PM, Sabater Lleal M, de Vries P, et al
    Association Between Hemostatic Profile and Migraine: A Mendelian Randomization Analysis.
    Neurology. 2021 Apr 1. pii: WNL.0000000000011931.
    PubMed     Abstract available
    
    
    February 2021
79. YU AYX, Hill MD, Asdaghi N, Boulanger JM, et al
    Sex Differences in Diagnosis and Diagnostic Revision of Suspected Minor Cerebral Ischemic Events.
    Neurology. 2021;96:e732-e739.
    PubMed     Abstract available
    
    
    January 2021
80. VAN CASTEREN DS, Kurth T, Danser AHJ, Terwindt GM, et al
    Sex Differences in Response to Triptans: A Systematic Review and Meta-analysis.
    Neurology. 2021;96:162-170.
    PubMed     Abstract available
    
    
    November 2020
81. RIGGINS NY, Sawhney H, Ehrlich A, Parekh M, et al
    Inpatient infusion treatments of headache in patients with chronic migraine and a reported history of head trauma and endocrine co-morbidities.
    Neurology. 2020;95.
    PubMed     Abstract available
    
    
    
82. ROBBINS MS, Victorio MC, Bailey M, Cook C, et al
    Quality improvement in neurology: Headache Quality Measurement Set.
    Neurology. 2020;95:866-873.
    PubMed    
    
    
    October 2020
83. LIPTON RB, Fanning KM, Buse DC, Martin VT, et al
    Author response: Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2020;95:707-708.
    PubMed    
    
    
    
84. GUPTA VK
    Reader response: Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2020;95:707.
    PubMed    
    
    
    
85. SIEGLER JE 3RD, Galetta S
    Editors' note: Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2020;95:706.
    PubMed    
    
    
    
86. SASIKUMAR S, Micieli JA, Oh J
    Mystery Case: Migraine, hearing loss, and blurred vision in a young woman.
    Neurology. 2020 Oct 12. pii: WNL.0000000000011034.
    PubMed    
    
    
    September 2020
87. KORNBLUH AB, Chung MG
    Teaching NeuroImages: Transient cytotoxic edema in a child with a novel ATP1A2 mutation.
    Neurology. 2020;95:e1441-e1442.
    PubMed    
    
    
    August 2020
88. SALTER A, Kowalec K, Fitzgerald KC, Cutter G, et al
    Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
    Neurology. 2020;95:e446-e456.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.